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Advances in Campylobacter biology and implications for biotechnological
applications
Abstract
Campylobacter jejuni is a major foodborne pathogen of animal origin and a leading cause of bacterial
gastroenteritis in humans. During the past decade, especially since the publication of the first C. jejuni
genome sequence, major advances have been made in understanding the pathobiology and physiology of this
organism. It is apparent that C. jejuni utilizes sophisticated mechanisms for effective colonization of the
intestinal tracts in various animal species. Although Campylobacter is fragile in the environment and requires
fastidious growth conditions, it exhibits great flexibility in the adaptation to various habitats including the
gastrointestinal tract. This high adaptability is attributable to its genetically, metabolically and phenotypically
diverse population structure and its ability to change in response to various challenges. Unlike other enteric
pathogens, such as Escherichia coli and Salmonella, Campylobacter is unable to utilize exogenous glucose and
mainly depends on the catabolism of amino acids as a carbon source. Campylobacter proves highly mutable in
response to antibiotic treatments and possesses eukaryote-like dual protein glycosylation systems, which
modify flagella and other surface proteins with specific sugar structures. In this review we will summarize the
distinct biological traits of Campylobacter and discuss the potential biotechnological approaches that can be
developed to control this enteric pathogen.
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Summary
Campylobacter jejuni is a major foodborne pathogen
of animal origin and a leading cause of bacterial
gastroenteritis in humans. During the past decade,
especially since the publication of the first C. jejuni
genome sequence, major advances have been made
in understanding the pathobiology and physiology of
this organism. It is apparent that C. jejuni utilizes
sophisticated mechanisms for effective colonization
of the intestinal tracts in various animal species.
Although Campylobacter is fragile in the environment
and requires fastidious growth conditions, it exhibits
great flexibility in the adaptation to various habitats
including the gastrointestinal tract. This high adapt-
ability is attributable to its genetically, metabolically
and phenotypically diverse population structure and
its ability to change in response to various chal-
lenges. Unlike other enteric pathogens, such as
Escherichia coli and Salmonella, Campylobacter is
unable to utilize exogenous glucose and mainly
depends on the catabolism of amino acids as a
carbon source. Campylobacter proves highly mutable
in response to antibiotic treatments and possesses
eukaryote-like dual protein glycosylation systems,
which modify flagella and other surface proteins with
specific sugar structures. In this review we will
summarize the distinct biological traits of Campylo-
bacter and discuss the potential biotechnological
approaches that can be developed to control this
enteric pathogen.
Introduction
Campylobacter is a microaerophilic Gram-negative bac-
terium and is among the leading causes of human
gastroenteritis (Allos, 2001; Olson et al., 2008), respon-
sible for 400–500 million cases of infection each year
worldwide (Ruiz-Palacios, 2007). Campylobacteriosis in
humans presents as diarrhoea, fever and abdominal
cramps and is recognized as a major risk factor for the
onset of Guillain-Barré syndrome, which is a serious post-
infection complication characterized by acute and pro-
gressive neuromuscular paralysis (Allos, 2001). Among
Campylobacter species, Campylobacter jejuni accounts
for more than 92% of human infections (Friedman et al.,
2000; Gillespie et al., 2008) with an infectious dose as low
as 500 bacteria (Robinson, 1981). The organism is trans-
mitted to humans through a variety of sources, such as
contact with infected pets or consumption of contami-
nated water or milk. However, the most frequent source of
C. jejuni infection is contaminated, undercooked poul-
try meat (Olson et al., 2008). Campylobacter-induced
enteritis is usually self-limiting and does not require anti-
microbial treatment, but clinical therapy, often using eryth-
romycin or fluoroquinolone antibiotics, is warranted for
cases involving high fever, bloody diarrhoea or immuno-
compromised patients (Blaser and Engberg, 2008). The
increasing prevalence of drug-resistant Campylobacter
has compromised the effectiveness of these antibiotics
and poses a significant threat to public health in many
countries (Blaser and Engberg, 2008).
Facilitated by the decoding of genome sequences, our
understanding of Campylobacter as a zoonotic pathogen
significantly advanced in the last decade. The progress is
especially prominent in the areas of metabolic pathways,
genetic variability, adaptation mechanisms, protein glyco-
sylation systems, colonization factors and molecular basis
of antibiotic resistance. These recent advances reveal
distinct features of this pathogenic organism, provide new
insights into Campylobacter physiology and pathobiology,
and open potential avenues for the development of
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intervention strategies to prevent and control Campylo-
bacter colonization in animal reservoirs and infection of
the human host. This review will summarize these
advances with a particular emphasis on the unique
aspects of Campylobacter biology. The implications of
these findings for biotechnological applications will also
be discussed. Detailed discussion on Campylobacter
pathogenesis and host immune responses has been pre-
sented in several recent review papers (Young et al.,
2007; Janssen et al., 2008; Poly and Guerry, 2008; Zil-
bauer et al., 2008) and will not be a focus of this review.
Central metabolism and carbon flux surrounding
pyruvate
With the exception of 6-phosphofructokinase (Pfk), C.
jejuni maintains a complete Embden-Meyerhof-Parnas
(EMP) pathway and citric acid cycle (CAC) (Parkhill et al.,
2000). Although C. jejuni possesses a fructose-1,6-
bisphosphatase orthologue (Fbp) (Velayudhan and Kelly,
2002), the lack of Pfk results in the inability to catalyse the
conversion of fructose-6-phosphate to fructose-1,6-
bisphosphate (Fig. 1) and consequently renders this
organism unable to utilize exogenous glucose (Van-
damme et al., 2005). Pyruvate is a central metabolite
connecting the EMP pathway and CAC, but is not formed
from glucose in C. jejuni; yet acetyl-CoA is still formed in
the cell (Mendz et al., 1997; St Maurice et al., 2007).
Many anaerobes produce acetyl-CoA from the oxidative
decarboxylation of pyruvate catalysed by pyruvate :
ferredoxin oxidoreductase (PFOR) and reduce ferredoxin
(White, 2007). Different from these anaerobes, members
of the e-proteobacteria including C. jejuni use flavodoxin
as the preferred electron carrier (Cremades et al.,
2005). Campylobacter jejuni homologues of flavoprotein
(FldA; Cj1382c) and flavodoxin : quinole reductase
(Fqr; Cj0559) are likely involved in this process.
An endogenous source of pyruvate is the catabolism of
glucogenic amino acids producing a-keto or a-oxoacids
(Fig. 1). Thus, amino acids likely play an important
role in Campylobacter metabolism (Guccione et al.,
2008). Several amino acids, particularly L-aspartate,
L-glutamate, L-serine and L-proline, are significantly
depleted from the culture media by C. jejuni strain NCTC
11168 (Guccione et al., 2008), and the ability to utilize
L-asparagine and glutathione is highly strain-specific
Fig. 1. Central metabolism of C. jejuni and carbon flux surrounding pyruvate. Pathways and reactions are distinguished by the colour of
arrows connecting intermediates; blue, possible anabolic role of EMP pathway; magenta, preferred amino acid catabolism; green, potential
futile cycle; black, oxidative citric acid cycle and pyruvate carboxylation/decarboxylation. This composite figure is adapted from previously
published information (Velayudhan and Kelly, 2002; St Maurice et al., 2007; Guccione et al., 2008).
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(Hofreuter et al., 2008). Transamination of alanine, possi-
bly by putative aminotransferases (Cj0762c or Cj0150c),
and dehydration of serine by SdaA (Velayudhan et al.,
2004) will each produce pyruvate. Proline is converted to
glutamate through a glutamate-5-semialdehyde interme-
diate (Cj1503c, PutA), and subsequent transamination of
glutamate and oxaloacetate by AspB will produce
a-ketoglutarate and aspartate (Guccione et al., 2008).
The deamination of aspartate by AspA yields fumarate
(Guccione et al., 2008). Fumarate and a-ketoglutarate,
formed from these amino acids, can enter the CAC.
Malate is converted to pyruvate by the malic enzyme
(MEZ), and oxaloacetate is first converted to phospho-
enolpyruvate (PEP) by phosphoenolpyruvate carboxyki-
nase (PckA) and then to pyruvate by pyruvate kinase
(Pyk) (Velayudhan and Kelly, 2002; Sauer and Eikmanns,
2005). The lack of a PEP synthase in C. jejuni suggests
that decarboxylation of oxaloacetate by PckA is the main
mechanism of PEP production (Velayudhan and Kelly,
2002). Consistent with this notion, a pckA mutant could
not be constructed, thus pckA is likely an essential gene in
C. jejuni (Velayudhan and Kelly, 2002). Although the lack
of Pfk results in the inability to utilize exogenous glucose,
the presence of an Fbp orthologue (Cj0840c) strongly
suggests an anabolic role for the EMP pathway, requiring
the synthesis of PEP. Anabolically formed glucose may
have several metabolic fates, including incorporation into
lipooligosaccharides (LOS), capsular polysaccharides
(CPS), or protein glycans or entry into the pentose phos-
phate pathway. Interestingly, the C. jejuni genome
encodes a functional pyruvate kinase (Pyk), posing a
potential futile cycle between PEP, pyruvate and oxaloac-
etate and resulting in the net loss of one ATP (Velayudhan
and Kelly, 2002). The role of Pyk in Campylobacter
metabolism remains unclear, but may be involved in the
catabolism of PEP derived from an unknown substrate
that enters the EMP pathway subsequent to the formation
of fructose-1,6-bisphosphate (Velayudhan and Kelly,
2002).
Aerobic and anaerobic respiration
The highly branched electron transport system of C. jejuni
is capable of both anaerobic and aerobic respiration
(Fig. 2), affording this organism the flexibility to respire
under varying levels of available electron donors and ter-
minal acceptors. Additionally, branches that use terminal
oxidases with high oxygen affinity remove trace oxygen,
thereby creating a low intracellular oxygen state that is
conducive to the activity of oxygen sensitive enzymes and
the use of alternative terminal electron acceptors. Early
reports on the respiratory system of C. jejuni reported high
activities when membrane vesicles were incubated with
hydrogen and formate, moderate rates with malate, suc-
cinate and lactate, and poor activity with NADH as elec-
tron donors (Hoffman and Goodman, 1982). Sulfite, which
is normally an inhibitory substance added to food as a
preservative, is a respiratory substrate for C. jejuni (Myers
and Kelly, 2005). A gluconate dehydrogenase (GADH)
was recently reported to enable C. jejuni to respire using
gluconate as an electron donor at elevated temperatures.
Mutation of GADH led to a marked impairment in the
colonization of poultry intestines (Pajaniappan et al.,
2008). Campylobacter jejuni possesses a cluster of
genes (nuoA-N) encoding homologues of the NADH :
ubiquinone oxidoreductase complex (also known as
NADH dehydrogenase or Complex I in other bacteria)
(Parkhill et al., 2000). Most of the genes that encode
Fig. 2. Schematic diagram of the highly branched respiratory pathway in C. jejuni. APrimary dehydrogenases that oxidize formate, hydrogen,
lactate and succinate. Electrons from gluconate likely enter at the level of cytochrome c. BReductases that transfer electrons onto fumarate,
nitrate, nitrite and S-and N-oxides. Bold type: potential coupling sites associated with proton translocation and energy conservation. MK,
Menaquinone pool.
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Complex I are intact except for homologues of the NADH
dehydrogenase subunits (nuoE and nuoF), accounting for
the poor respiratory ability of C. jejuni using NADH as an
electron donor (Hoffman and Goodman, 1982). In their
place within the operon are two genes (Cj1574c and
Cj1575c) of unknown function (Weerakoon and Olson,
2008), and it is hypothesized that Cj1574c and Cj1575c
accept electrons from reduced flavoprotein (FldA), rather
than NADH (Weerakoon and Olson, 2008). Analysis of
the C. jejuni NCTC 11168 genome revealed no a-
ketoglutarate dehydrogenase homologue; however, OOR
(encoded by oorDABC) is a functionally equivalent redox
complex that catalyses the conversion of a-ketoglutarate
to succinyl-CoA (Hughes et al., 1998) and transfers elec-
trons to FldA (Weerakoon and Olson, 2008), providing a
source of electrons for Complex I.
In C. jejuni, the electron flow from donor to acceptor,
through dehydrogenases to reductases, and oxidases, is
carried by lipid-soluble menaquinone and two types of
cytochromes (b- and c-type). Although menaquinone can
be detected from members of the Campylobacter genus
(Moss et al., 1984), the C. jejuni genome reveals no
obvious homologues to the Escherichia coli MenZ-G
enzymes catalysing the conversion of chorismate to
menaquinone (Parkhill et al., 2000). An alternative
pathway for menaquinone synthesis, termed the futa-
losine pathway, was recently described in Streptomyces
coelicolor (Hiratsuka et al., 2008). This study suggested a
role for this alternative pathway in menaquinone synthesis
in C. jejuni.
Campylobacter is able to respire both aerobically and
anaerobically, utilizing oxygen or alternative electron
acceptors to terminate the electron transport chain.
Campylobacter jejuni possesses two terminal oxidases,
including a high-affinity cbb3-type cytochrome c oxidase
and a cyanide insensitive oxidase (Smith et al., 2000). In
terms of aerobic respiration through the high-affinity
oxidase, electrons fed into the menaquinone pool are
transferred to cytochrome bc1 (Complex III) then to a
periplasmic cytochrome c (Fig. 2). The cbb3-type oxidase
(CcoNOPQ; Cj1487c-Cj1490c) has very high affinity for
oxygen (Km = 40 nM) (Jackson et al., 2007), which allows
C. jejuni to aerobically respire under oxygen-limiting con-
ditions such as those encountered in a host’s intestine.
The second branch at the terminal oxidase level of
aerobic respiration is mediated by CioAB (cyanide insen-
sitive oxidase, formerly CydAB) and has a low affinity to
oxygen (Jackson et al., 2007). The CioA mutants colo-
nized the poultry intestine as efficiently as the wild-type,
but CcoN mutants were completely impaired in coloniza-
tion indicating a significant role for oxygen during in vivo
colonization (Weingarten et al., 2008). Although the con-
ditions encountered by C. jejuni within the animal host
may be considered anaerobic, it is plausible that oxygen
perfusion from actively respiring host epithelial cells
provide an oxygen gradient in the mucosal layer
approaching anoxic conditions near the intestinal lumen;
thus, the role of terminal oxidases, especially the high-
affinity cbb3-type, in the animal host may be energy con-
servation through scavenging host-provided oxygen
(Weingarten et al., 2008).
In addition to aerobic respiration, C. jejuni is capable of
anaerobic respiration. The electron transfer from cyto-
chrome c to H2O2 is facilitated by two different periplasmic
cytochrome c peroxidases (CCP; Cj0020c and Cj0358).
Although Cj0358 plays only a minor role in colonization
(Bingham-Ramos and Hendrixson, 2008), Cj0020c plays
an important role in chicken colonization and was named
docA (determinant of colonization) (Hendrixson and
Dirita, 2004). The contribution of periplasmic CCP to colo-
nization remains unclear, but may be involved in the
removal of endogenously produced H2O2 during formate
respiration (Atack and Kelly, 2007). Anaerobic respiration
in C. jejuni is also accomplished by a variety of reductases
that transfer electrons from the menaquinone pool onto
fumarate (FrdABC; Cj0408-Cj0410), nitrate (NapAB;
Cj0780 and Cj0781), nitrite (NrfA; Cj1357c) and N- and
S-oxides (TorAC; Cj0264c and Cj0265c) (Sellars et al.,
2002; Pittman et al., 2007). While the high-affinity cbb3-
type terminal oxidase plays a significant role in the
colonization of poultry intestines, the role of terminal
reductases is less clear. TorA plays a minimal role in
poultry colonization (Weingarten et al., 2008) with conflict-
ing evidence presented for respiration using nitrate
(Pittman et al., 2007; Weingarten et al., 2008). These dis-
crepancies may be attributed to genetic differences
among strains, inoculum dose, or diet fed to the chickens
and microbiota of the chicken intestine affecting the pro-
duction or availability of terminal electron acceptors. The
versatile respiratory system of Campylobacter provides
for the cell’s energy demands and detoxifies potentially
damaging compounds, such as nitrite, nitric oxide and
sulfite.
Dual protein glycosylation systems in C. jejuni
Campylobacter jejuni possesses both O-linked and
N-linked protein glycosylation systems (Szymanski et al.,
2005; Guerry and Szymanski, 2008). The N-linked pro-
tein glycosylation occurs at the carboxamide side-chain
of asparagine, while the O-linked protein glycosylation
system mediates the attachment of glycans to the
hydroxyl group of serine or threonine residues on a
protein. Flagellin is the only O-glycoprotein in C. jejuni and
is extensively modified with pseudaminic acid (Thibault
et al., 2001). In C. jejuni NCTC 11168, the DNA locus
responsible for O-linked protein glycosylation consisting
of about 50 genes, and the glycosylation locus is highly
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variable among different strains of C. jejuni (Karlyshev
et al., 2005). Mutations eliminating glycans from flagella
reduced Campylobacter adherence to and invasion of
INT407 cells, decreased auto-agglutination and attenu-
ated diarrhoea in a ferret animal model (Guerry et al.,
2006). Thus, the Campylobacter flagella require glycosy-
lation to carry out its virulence-associated functions
(Guerry et al., 2006). It was believed that N-linked glyco-
proteins were exclusive to eukaryotes; however, recent
evidence of this post-translational modification has been
documented in archaea and eubacteria (Schaffer et al.,
2001). The first bacterial N-linked glycosylation pathway
was reported in C. jejuni (Szymanski et al., 1999), and
Campylobacter is the only bacterium known to possess
both O- and N-linked protein glycosylation systems to
date (Szymanski et al., 2005). N-linked protein glycosyla-
tion in C. jejuni is carried out by the pgl locus consisting of
11 genes (pglA-F, pglH-K and gne) (Szymanski et al.,
1999; Linton et al., 2002; Alaimo et al., 2006; Kelly et al.,
2006). Analogous to dolichyl-phosphate in eukaryotes,
undecaprenyl-phosphate serves as a carrier for the
cytosolic addition of UDP-activated oligosaccharides
(Feldman et al., 2005). PglD, PglE and PglF convert UDP-
N-acetyl glucosamine (GlcNAc) to UDP-bacillosamine
that is attached to the undecaprenyl pyrophosphate by
PglC. The gne gene encodes an epimerase that intercon-
verts glucose and GlcNAc to galactose and N-acetyl
galactosamine (GalNAc), respectively. Sequential addi-
tion of GalNAc residues are achieved by the transferase
activities of PglA, PglJ and PglH, with PglI forming the
branching b1,3 bond to glucose (Glover et al., 2005;
Linton et al., 2005). The entire heptasaccharide is flipped
across the cytoplasmic membrane into the periplasm by
PglK (formerly WlaB) (Alaimo et al., 2006; Kelly et al.,
2006), and transferred to the Asn residue of the D/E-X1-
N-X2-S/T (X1 and X2 are any amino acids other than
proline) glycan accepting sequon by PglB, an oligosac-
charyl transferase (Kowarik et al., 2006). The bacterial
glycan acceptor sequon requires the negatively charged
side-chain of aspartate or glutamate at the -2 position,
which is not required by eukaryotes, suggesting that C.
jejuni has a more specific attachment site of the N-glycan
than eukaryotes (Kowarik et al., 2006). Interestingly, the
C. jejuni pgl gene cluster also functionally mediates
N-linked protein glycosylation in E. coli and can modify
proteins with diverse glycan structures (Feldman et al.,
2005; Wacker et al., 2006).
Genetic and phenotypic instability
A distinct feature of Campylobacter is its genetic and
phenotypic instability resulting from high-frequency muta-
tion and horizontal gene transfer. The instability results in
remarkable strain-to-strain variations, creating a signifi-
cant obstacle for deciphering gene functions in Campylo-
bacter. The high mutation rate is attributable to an
incomplete mismatch DNA repair system. The mutH,
mutL, mutS and uvrD genes are key components of the
mismatch repair system in bacteria, and mutants defec-
tive in any of these genes show a hypermutable pheno-
type with a 100- to 1000-fold increase in mutation
frequency (Miller, 1996). Campylobacter jejuni does not
have mutH, mutL and uvrD homologues, but has a variant
copy of mutS (mutS2) (Parkhill et al., 2000). MutS2,
however, is not involved in mismatch repair and was
shown to suppress intergenomic recombination in Helico-
bacter pylori (Kang et al., 2005). The inability of C. jejuni
to recognize and repair mismatch errors through the
MutHLS complex may lead to the observed high fre-
quency of spontaneous point mutations and phase varia-
tion, contributing to genetic diversity in Campylobacter.
Horizontal gene transfer is also involved in generat-
ing genetic variation in Campylobacter. Comparative
genomic studies revealed that C. jejuni has hypervariable
gene clusters, which are located on chromosome and
functionally associated with biosynthesis of surface struc-
tures (LOS, CPS and flagella) and restriction–modification
systems (Parkhill et al., 2000; Taboada et al., 2004).
These hypervariable clusters have a different G+C com-
position from that of the rest of the chromosome (Parkhill
et al., 2000; Hofreuter et al., 2006), suggesting that hori-
zontal gene transfer may be responsible for their acquisi-
tion. Natural transformation, conjugation and transduction
are the mechanisms of horizontal gene transfer in bacte-
ria, and C. jejuni can use all three mechanisms. Natural
transformation significantly contributes to genetic diversity
and the spread of antibiotic resistance determinants in
this bacterium. For example, co-culture or co-colonization
of C. jejuni strains harbouring different antibiotic resis-
tance markers generated C. jejuni populations possess-
ing resistance to multiple antibiotics, and this process was
prevented in the Cj1211 mutant that was deficient in
natural transformation (de Boer et al., 2002; Jeon et al.,
2008). Although a complete understanding of the overall
mechanism of natural transformation is still lacking and
the recognition sequence for natural transformation has
not been identified in Campylobacter, multiple factors
contributing to this process have been reported (Guerry
et al., 1994; Wiesner et al., 2003; Larsen et al., 2004;
Jeon and Zhang, 2007; Jeon et al., 2008; 2009).
Compared with natural transformation, limited informa-
tion is available for conjugation and transduction in
Campylobacter. Campylobacter jejuni strain RM1221 con-
tains a Mu-like prophage located in its chromosome
(Fouts et al., 2005), which was not found in the genome
sequence of C. jejuni NCTC 11168 (Parkhill et al., 2000).
The Mu-like bacteriophage present in strain RM1221
appears to be widely prevalent in many C. jejuni and C.
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coli strains and contributes to the genetic diversity of this
genus (Parker et al., 2006; Clark and Ng, 2008). Recently,
evidence of intragenomic and interstrain recombination,
mediated by bacteriophages, was reported in C. jejuni
(Scott et al., 2007a,b). Conjugative plasmids have been
described in Campylobacter (Taylor et al., 1981; Bacon
et al., 2000), which were transferrable between different
strains in culture media and in the avian intestine (Avrain
et al., 2004). The exact contribution of conjugation and
transduction to genetic diversity in Campylobacter awaits
further investigation.
Flagellum-mediated motility and secretion of
virulence factors
The motility of Campylobacter is imparted by polar flagella
and is recognized as an important virulence factor. Chal-
lenge of human volunteers with a mixture of motile and
non-motile C. jejuni resulted in the isolation of only motile
C. jejuni (Black et al., 1988), implying a significant role of
motility in colonization. Flagella are involved in auto-
agglutination (Misawa and Blaser, 2000) and biofilm for-
mation (Joshua et al., 2006; Kalmokoff et al., 2006).
Structurally, the flagellar filament consists of flagellin
subunits encoded by two tandem genes, flaA and flaB
(Nuijten et al., 1990; Guerry et al., 1991). While the
expression of flaA, encoding the major flagellin (FlaA)
subunit, is s28-dependent (Nuijten et al., 1990; Guerry
et al., 1991), flaB is expressed by a s54-dependent pro-
moter and produces the minor flagellin (FlaB) subunit
(Guerry et al., 1991). FlaA and FlaB are highly immuno-
genic (Shoaf-Sweeney et al., 2008), although immune
recognition is independent of toll-like receptor 5
(Andersen-Nissen et al., 2005). Mutation of flaA, but not
flaB, reduced motility significantly, rendered Campylo-
bacter less invasive to human INT407 cells and
decreased the level of chicken colonization (Guerry et al.,
1991; Wassenaar et al., 1991; 1993). Although the flaA
mutation affected both auto-agglutination and biofilm
formation, flaB is only involved in biofilm formation but
not auto-agglutination (Golden and Acheson, 2002;
Kalmokoff et al., 2006). Analysis of the genome sequence
of C. jejuni identified two additional flagellin paralogues,
flaC (Cj0720c) and flaD (Cj0887c) (Parkhill et al., 2000).
Inactivation of flaC did not affect motility, but reduced
invasion of HEp-2 cells (Song et al., 2004) and pellicle
formation (Kalmokoff et al., 2006). Similar to the flaA
mutation, the flaD mutation caused defects in motility and
auto-agglutination; however, FlaD is not detected in the
flagellar filament of C. jejuni (Golden and Acheson, 2002).
Flagellar expression is subject to phase variation and
contributes to the unstable motile phenotype in Campylo-
bacter. Phase variation between motile and non-motile
phenotypes occurs frequently in vitro and in vivo (Caldwell
et al., 1985; Karlyshev et al., 2002; Hendrixson, 2006;
2008), and is mediated by slipped-strand mispairing pri-
marily in homopolymeric or occasionally heteropolymeric
tracts, resulting in frameshift mutations in the genes asso-
ciated with flagellar biosynthesis and regulation (flhA,
flgS, flgR and maf) (Park et al., 2000; Karlyshev et al.,
2002; Hendrixson, 2006; 2008). The high-frequency
phase variation was attributed to the A/T-rich genetic
content of the C. jejuni chromosome and the absence of
an intact mismatch repair system (Hendrixson, 2006).
The flagellar apparatus in C. jejuni is involved in
secretion of virulence-associated proteins, such as Cia,
FlaC and FspA. Cia (Campylobacter invasion antigen)
proteins are associated with C. jejuni invasion of INT407
cells (Konkel et al., 1999), and their secretion requires
the function of the flagellar basal body, hook and fila-
ment (Konkel et al., 2004). Mutation of the basal rod
(flgF) and hook (flgE) elements prevented the secretion
of FlaC, suggesting that FlaC is secreted via the flagellar
apparatus. Secreted FlaC binds to HEp-2 cells and the
FlaC mutant demonstrated reduced invasion compared
with the wild-type strain (Song et al., 2004). FspA
(flagellar secreted protein), a small acidic protein, is
secreted by the flagellar system in C. jejuni (Poly et al.,
2007). Although the exact function of FspA is unknown,
a variant of FspA (FspA2) induced apoptosis in INT407
cells. Given the fact that C. jejuni lacks a typical type III
secretion system, the flagellar secretion apparatus is
likely an alternative mechanism for secretion of virulence
factors in this pathogen.
Adaption to environmental stresses
As a fastidious, asaccharolytic and microaerobic bacte-
rium, C. jejuni utilizes elaborate adaptation mechanisms
to survive environmental stresses (Murphy et al., 2006),
such as temperature shift, oxygen tension and nutrient
depletion, which occur during transmission between the
environment and animal hosts and within the host’s intes-
tine. The minimal temperature at which C. jejuni can grow
is between 31°C and 32°C, with an optimal growth tem-
perature of 42°C (Hazeleger et al., 1998). Unlike E. coli,
C. jejuni lacks the genes encoding the key components of
cold shock response such as CspA (Parkhill et al., 2000),
which facilitates protein synthesis by blocking the forma-
tion of unfavorable secondary structures in mRNAs during
cold shock (Jiang et al., 1997). Temperature downshift
to below the minimal growth temperature resulted in
massive downregulation of gene expression, including
those involved in biosynthesis of macromolecules;
however, some genes encoding heat shock proteins,
chaperones and energy metabolism were upregulated,
suggesting that C. jejuni utilizes active mechanisms for
adaptation to low temperatures (Moen et al., 2005). Tem-
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perature upshift (from 37°C to 42°C) led to upregulation of
genes encoding heat shock proteins, chaperones and
chaperonins, and downregulation of genes encoding ribo-
somal proteins (Stintzi, 2003). These findings suggest that
with both temperature upshift and downshift C. jejuni
reduces energy consumption and invokes the heat shock
protection mechanism.
RpoS, a sigma factor associated with stationary phase
response, is absent in C. jejuni (Parkhill et al., 2000).
Despite this fact, active transcriptomic, metabolic and
phenotypic changes occur in Campylobacter during the
transition from exponential to stationary phase, including
downregulation of genes associated with electron
transport and protein synthesis, induction of protection
mechanisms (heat shock response and oxidative stress
resistance), shift in nutrient utilization and increase in
motility (Wright et al., 2009). For effective colonization and
infection, C. jejuni must be able to survive acid stresses
in the stomach. Exposure to acid stress in vitro and
in vivo (piglet stomach) induced the expression of genes
involved in heat shock response and oxidative stress
resistance (Reid et al., 2008). DNA microarray profiles of
Campylobacter transcripts recovered from rabbit ileal
loops, into which C. jejuni was directly inoculated without
passing through the stomach, showed marked upregula-
tion of the genes involved in oxidative stress response,
heat shock response, iron metabolism, bile resistance
(cmeABC), flagellar biosynthesis and the stringent
response (Stintzi et al., 2005), suggesting that C. jejuni
utilizes sophisticated mechanisms for adaptation in the
intestinal environment. SpoT, a key regulator for stringent
response, modulates Campylobacter survival in station-
ary phase and the resistance to oxidative stress and
rifampicin (Gaynor et al., 2005). Expression of spoT was
upregulated upon contact with INT407 cells and inactiva-
tion of spoT in Campylobacter reduced adherence,
invasion and intracellular survival (Gaynor et al., 2005).
Together, these findings suggest that modulating the
expression of genes involved in heat shock response and
oxidative stress may be a common mechanism utilized by
Campylobacter to adapt to various stresses.
Mechanisms for in vivo colonization
As a zoonotic pathogen, Campylobacter colonizes the
gastrointestinal tracts of a variety of animal hosts, either
as a commensal or as a pathogen. Understanding the
mechanisms Campylobacter uses for colonization may
yield control strategies. In particular, C. jejuni colonization
of the chicken intestinal tract has received considerable
attention because faecal contamination of chicken car-
casses during the slaughter process poses a significant
risk for human exposure. To date, flagella and motility are
the most well-defined colonization factors, and it is clear
that non-motile Campylobacter cannot establish coloniza-
tion in animal intestinal tracts. In addition, recent work
also identified other factors that are required for effective
colonization.
Adherence to epithelial cells of the intestine may be
required for C. jejuni to resist intestinal peristalsis and
expulsion. Several proteins have been identified in
Campylobacter that mediate adherence to cultured cells
including flagella (McSweegan and Walker, 1986), CadF
(Campylobacter adhesion to fibronectin) (Konkel et al.,
1997), PEB1a (Pei et al., 1998), PEB4 (Asakura et al.,
2007) and JlpA (jejuni lipoprotein A) (Jin et al., 2001).
Proteomic analysis demonstrated that FlaA, CadF, PEB1a
and PEB4 are associated with the membrane fraction and
are recognized by convalescent human sera (Cordwell
et al., 2008). Consistent with their function in cellular
adherence, most of these proteins are associated with the
colonization of animal hosts. For example, mutations of
peb1a and peb4 decreased murine colonization (Pei
et al., 1998; Asakura et al., 2007), and a CadF mutant
demonstrated impaired colonization in chickens (Ziprin
et al., 1999).
Bile is normally present in intestinal tracts and is a
natural detergent with antimicrobial activities. Thus, resis-
tance to bile is an essential mechanism for enteric bacte-
ria to colonize animal intestines. In Campylobacter, bile
resistance is primarily mediated by the CmeABC multi-
drug efflux pump (Lin et al., 2002; 2003). The CmeABC
mutant was completely impaired for colonization of the
chicken intestine due to the drastically increased sensitiv-
ity to bile compounds (Lin et al., 2003). Consistent with its
important role in bile resistance and in vivo colonization,
cmeABC is inducible by bile salts in culture media (Lin
et al., 2005b). The induced expression of cmeABC in the
intestine was also demonstrated in a rabbit ileal loop
model using DNA microarray (Stintzi et al., 2005). These
findings indicate that CmeABC is an important factor for
Campylobacter adaptation in bile-containing environ-
ments including the intestinal tract.
Another important determinant for successful coloniza-
tion is the ability to acquire adequate nutrients in vivo.
Amino acids are the primary carbon source for Campylo-
bacter with the preferred use of aspartate, glutamate,
serine and proline (Guccione et al., 2008). Mutation of
genes involved in the catabolism of aspartate (aspA)
(Guccione et al., 2008) and serine (sdaA) (Velayudhan
et al., 2004) reduced chicken colonization. Additionally,
sdaA expression is upregulated during chicken coloniza-
tion (Woodall et al., 2005), further suggesting an impor-
tant role for serine catabolism during intestinal colo-
nization. Recently, strain-specific utilization of asparagine,
glutamine and glutathione was described in C. jejuni
strain 81-176, and the ability to utilize these substrates
was correlated with enhanced colonization of specific
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tissues in mice (Hofreuter et al., 2008). The strain-
dependent substrate utilization is due to the presence of
g-glutamyl transpeptidase (GGT) and an exported form of
asparaginase (AnsB) in C. jejuni 81-176. The ggt gene is
also present in C. jejuni strain 81116 and mutation of this
gene significantly reduced the duration of C. jejuni colo-
nization in murine and avian hosts (Hofreuter et al., 2006;
Barnes et al., 2007). In addition, signature-tagged trans-
poson mutagenesis identified multiple genes contribut-
ing to C. jejuni colonization in chickens and some of
the identified genes encode amino acid transporters
(Hendrixson and Dirita, 2004).
The C. jejuni glycome also contributes to colonization of
animal intestines. Mutation of genes necessary for
N-linked protein glycosylation reduced Campylobacter
colonization in chickens (Hendrixson and Dirita, 2004;
Jones et al., 2004; Karlyshev et al., 2004; Kelly et al.,
2006). Mutagenesis of all putative N-glycosylated proteins
in C. jejuni identified Cj1496c as a colonization determi-
nant, but glycosylation of this protein did not seem to be
required for its function in colonization (Kakuda and Dirita,
2006). Capsular polysaccharides influence Campylo-
bacter colonization and virulence. A kpsM mutant of C.
jejuni strain NCTC 11168 demonstrated a complete lack of
colonization in chickens (Jones et al., 2004), and a kpsM
mutation in a different strain (81-176) reduced the inva-
sion of INT 407 cells and decreased the development of
diarrhoea in the ferret model (Bacon et al., 2001).
Multiple two-component regulatory systems (12
response regulators and 7 sensor kinases in strain NCTC
11168) have been identified in C. jejuni (Parkhill et al.,
2000; Fouts et al., 2005), and several of them were shown
to play a role in intestinal colonization. RacRS (reduced
ability to colonize) modulates Campylobacter gene expres-
sion in a temperature-dependent manner. The racR muta-
tion reduced bacterial growth at 42°C and impaired C.
jejuni colonization in chickens (Bras et al., 1999). Inactiva-
tion of DccRS (diminished capacity to colonize) did not
impair the growth of Campylobacter in culture media, but
resulted in a deficiency in the colonization of mice and
chickens (MacKichan et al., 2004). Inactivation of CbrR
(Campylobacter bile resistance regulator) rendered
Campylobacter more sensitive to bile salts than the wild-
type strain and significantly reduced chicken colonization,
presumably due to the increased sensitivity to bile
(Raphael et al., 2005). The cognate sensor kinase for CbrR
and how it regulates bile resistance are still unknown.
FlgRS is a two-component regulatory system associated
with the expression of flagellin subunit genes (Hendrixson
and Dirita, 2003; Wösten et al., 2004), and mutation of
FlgRS reduced the colonization level in chickens (Hendrix-
son and Dirita, 2004; Wösten et al., 2004). These findings
suggest that two-component regulatory systems are
important for Campylobacter adaptation in the intestinal
tract, but in most cases the exact environmental stimuli
recognized by the two-component systems are unknown.
In addition to two-component regulatory systems, C.
jejuni also utilizes other transcriptional regulators for
adaptation and colonization. Some examples include Fur
and CmeR. As a transcriptional repressor, Fur controls
iron homeostasis and modulates the expression of mul-
tiple genes in C. jejuni (van Vliet et al., 1998; Palyada
et al., 2004). Mutation of Fur significantly reduced the
colonization of Campylobacter in chickens (Palyada et al.,
2004). CmeR belongs to the TetR family of transcriptional
regulators (Ramos et al., 2005). In Campylobacter, CmeR
functions as a repressor for CmeABC and modulates the
expression level of this efflux pump (Lin et al., 2005a). A
recent study using DNA microarray also revealed that
CmeR is a pleiotropic regulator affecting the expression of
multiple genes and is required for optimal colonization of
Campylobacter in chickens (Guo et al., 2008). The regu-
lation of cmeABC by CmeR is through direct binding of
CmeR to the promoter region of cmeABC (Lin et al.,
2005a). Bile compounds inhibit the binding of CmeR to
the promoter DNA of cmeABC (Lin et al., 2005b), which
explains why bile salts induce the expression of cmeABC.
The recent crystallization work revealed a two-domain
structure of CmeR, including a DNA-binding motif formed
by the N-termini of the CmeR dimer and a large tunnel-like
ligand-binding cavity in the C-terminal domain of each
monomer (Gu et al., 2007; Routh et al., 2009). The tunnel
is surrounded by mostly hydrophobic residues and is pre-
dicted to be able to accommodate large, negatively
charged bile acid molecules. Based on the structural data
and the fact that bile compounds induced the expression
of CmeR-regulated genes (Guo et al., 2008), it is specu-
lated that bile acids and potentially other unidentified
signals in the gut interact with the ligand-binding pocket of
CmeR, which triggers a conformational change in the
DNA-binding domain, leading to the release of CmeR
from its target promoters. A model illustrating the regula-
tory mechanism of CmeR is shown in Fig. 3.
Mechanisms of antibiotic resistance
Campylobacter has developed resistance to multiple anti-
biotics and the general resistance mechanisms to clinically
important antibiotics are illustrated in Fig. 4 and reviewed
elsewhere (Zhang and Plummer, 2008). Depending on
their chemical and structural properties, antibiotics enter
bacterial cells through different routes. Small hydrophilic
antibiotics can pass through membrane porins, while
hydrophobic antibiotics diffuse through the lipid membrane
(Nikaido, 2003). The first obstacle for antibiotics is cell
permeability, which is affected by various membrane and
surface structures. Campylobacter jejuni has both LOS
and CPS, which contribute to the hydrophilic nature of the
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bacterial surface. A recent study demonstrated that
mutagenesis of LOS, but not CPS, significantly sensitized
C. jejuni (strain NCTC 11168) to erythromycin, a hydropho-
bic macrolide antibiotic, suggesting that LOS reduces the
permeability to hydrophobic antibiotics (Jeon et al., 2009).
Once antimicrobials traverse the cytoplasmic membrane,
they are extruded by multidrug efflux transporters, which
reduce the intracellular drug concentration and constitute a
second defence mechanism against antibiotics. Although
the genome sequences of C. jejuni revealed the presence
of multiple putative drug efflux transporters of different
families, most of them have not been functionally charac-
terized. CmeABC, an RND-type efflux transporter, appears
to be the primary drug efflux pump in Campylobacter and
confers resistance to structurally diverse antibiotics as well
as bile compounds (Lin et al., 2002; Pumbwe and Piddock,
2002). As discussed earlier, CmeABC is also required
for Campylobacter colonization in the chicken intestine
Fig. 3. CmeR regulation of gene expression in Campylobacter. In the absence of an inducer, dimeric CmeR binds to target promoters and
inhibit the expression of target genes (e.g. cmeABC). In the presence of an inducer (e.g. bile salts), the interaction of an inducer with the
C-terminal ligand-binding pocket of CmeR triggers a conformational change in the N-terminal DNA binding domain, preventing the binding of
CmeR to target promoters and leading to enhanced expression of target genes.
Fig. 4. Mechanisms associated with
Campylobacter resistance to macrolide and
fluoroquinolone antibiotics. LOS reduces the
uptake of hydrophobic antibiotics (e.g.
macrolide); efflux pumps (such as CmeABC
and other uncharacterized efflux transporters)
decrease the intracellular concentration of
antibiotics; and chromosomal mutations
reduce the affinity of antibiotics to their
targets. Mfd and the lack of an intact
mismatch repair system enhance the
spontaneous mutation rate in Campylobacter.
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(Lin et al., 2003). Thus, this efflux pump has an impor-
tant natural function in addition to conferring antibiotic
resistance.
Another mechanism utilized by Campylobacter for anti-
biotic resistance is target modification. Spontaneous point
mutations in the quinolone resistance determining region
of GyrA reduce the affinity of fluoroquinolones (FQs) to
DNA gyrase and result in resistance to this class of anti-
biotics (Engberg et al., 2001). Likewise, certain mutations
in the 23S rRNA subunit mediate resistance to macrolide
antibiotics (Gibreel et al., 2005). Due to the clinical impor-
tance of FQs and macrolides in treating campylobacterio-
sis, the rising prevalence of resistance to these two
classes of antibiotics, especially to FQs, has become a
concern for public health. Campylobacter has a high
mutation frequency (up to 10-6) for FQ resistance, which is
affected by the function of Mfd (Yan et al., 2006; Han
et al., 2008). Mfd is a transcription–repair coupling factor
involved in strand-specific DNA repair (Selby and Sancar,
1994). In contrast to its mutation-frequency-decline func-
tion in E. coli, the Mfd orthologue in C. jejuni actually
promotes the emergence of spontaneous FQ-resistant
mutants in Campylobacter (Han et al., 2008). Knocking
out the mfd gene in Campylobacter resulted in a 100-fold
reduction in the number of spontaneous mutants resistant
to ciprofloxacin, while overexpression of mfd increased
the mutant numbers, suggesting that Mfd modulates the
spontaneous mutation rates in Campylobacter. Due to the
high spontaneous mutation rate and adaptive response in
gene expression, FQ-resistant Campylobacter rapidly
emerge from a FQ-susceptible population when exposed
to FQ antibiotics. This has been shown by both in vitro and
in vivo treatment studies (McDermott et al., 2002; Luo
et al., 2003; Han et al., 2008) and represents a distinct
feature of FQ-resistance development in Campylobacter.
The resistance-conferring mutation in GyrA not only
affects the susceptibility of Campylobacter to FQ antibiot-
ics, but also modulates the fitness of this organism
because FQ-resistant Campylobacter can out-compete
FQ-susceptible Campylobacter in the absence of antibi-
otic selection pressure (Luo et al., 2005). In contrast to FQ
resistance, the spontaneous mutation rate to macrolide
resistance is low (< 10-9), and the development of stable
macrolide-resistant mutants appears to require long-term
exposure to the antibiotics (Lin et al., 2007; Luangtong-
kum et al., 2009), which explains, at least partly, why the
overall prevalence of macrolide-resistant Campylobacter
is lower than that of FQ-resistant Campylobacter.
Biotechnological approaches for control of
Campylobacter
Control of Campylobacter represents a major goal for
improving food safety and public health. As Campylo-
bacter is a foodborne pathogen of animal origin and is
transmitted to humans through the food chain, interven-
tion strategies should consider the ecological aspects of
the organism and can be designed to target the pathogen
in both animal and human hosts, as well as the different
segments of food production systems. Given the fact that
contaminated poultry meat is a major source of human
infections with Campylobacter, reduction of this pathogen
in commercial chickens both at the pre-slaughter and
post-slaughter stages has been a focus of investigation.
A quantitative risk assessment estimated that a two-log
reduction in the number of Campylobacter on chicken
carcasses could lead to a 30-fold reduction in the inci-
dence of human campylobacteriosis (Rosenquist et al.,
2003).
Bacteriophage therapy has received considerable
attention lately. Administering lytic bacteriophages
to artificially contaminated chicken carcasses or
Campylobacter-colonized chickens reduced the level
of C. jejuni contamination or colonization with varying
success (Atterbury et al., 2003; Loc et al., 2005;
Wagenaar et al., 2005). The efficacy of phage therapy is
affected by phage types and treatment doses (Loc et al.,
2005). In addition, treatment of Campylobacter coloniza-
tion with bacteriophages was shown to be effective only
for a short period, presumably due to development of
phage resistance (Loc et al., 2005; Wagenaar et al.,
2005). One potential way to avoid this limitation is to apply
this treatment to chickens in the final days preceding
slaughter, which may effectively reduce the quantity of
Campylobacter that are introduced to the abattoir and
consequently decrease chicken carcass contamination.
Recent advances in the field of metagenomics present
a novel approach to the rational design of competitive
exclusion products to potentially reduce Campylobacter
colonization. Previously, competitive exclusions were
attempted using culture-based, mucous-associated bac-
teria and yielded insufficient protection and inconsistent
results (Schoeni and Doyle, 1992; Schoeni and Wong,
1994). The culture-based method potentially misses key
constituents, such as fungi, anaerobes or fastidious
microbes, resulting in non-reproducible effects of this
treatment approach. The recently developed molecular
techniques, such as oligonucleotide fingerprinting of
rDNA genes (OFRG) (Patton et al., 2008) and high-
throughput pyrosequencing of rDNA genes (Qu et al.,
2008), provide powerful tools to assess the microbial
ecology of the gut. Application of OFRG, in conjunction
with antibiotic dissection of the microbial community in the
turkey ceca, revealed a possible association between the
presence of a subspecies of Megamonas hypermegale
and Campylobacter suppression (A. Scupham, pers.
comm.). As technology and data analysis methods
advance, it is possible that more effective competitive
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exclusion products can be developed to control Campy-
lobacter in animal reservoirs.
Bacteriocins are ribosomally synthesized peptides pro-
duced by bacteria that inhibit the growth of other bacteria
(Cotter et al., 2005). Several bacteriocins, notably bacte-
riocin OR-7 from Lactobacillus salivarius (Stern et al.,
2006) and E-760 from Enterococcus (Line et al., 2008),
demonstrated significant antagonistic effects on Campy-
lobacter. Administration of either bacteriocin to chickens
reduced the colonization level of Campylobacter by more
than 106 colony-forming units per gram of cecal contents
(Stern et al., 2006; Line et al., 2008). These results
suggest that bacteriocin treatment is a promising
approach for the control of Campylobacter. When used
prior to slaughter, this strategy may be effective in reduc-
ing chicken carcass contamination by Campylobacter.
Vaccines may be designed to prevent Campylobacter
infection in humans or in the chicken host. Various
approaches for immunization against Campylobacter
colonization in chickens have been discussed in a
recent review (de Zoete et al., 2007). Whole-cell vac-
cines appear to confer marginal protection in chickens
(Noor et al., 1995; Rice et al., 1997). Heterologous
expression of Campylobacter antigens in an attenuated
Salmonella strain has been used as a potential vector
vaccine for poultry immunization, and this approach was
met with varying success (Wyszynska et al., 2004;
Sizemore et al., 2006). Surface-exposed proteins, such
as flagellin, MOMP (the major outer membrane protein)
and adhesins (e.g. PEB1), may serve as potential
subunit vaccine candidates. For example, vaccination
of mice with recombinant FlaA or PEB1 demonstrated
partial protection against subsequent C. jejuni challenge
(Lee et al., 1999; Du et al., 2008). A CPS conjugate
vaccine of C. jejuni 81-176 provided complete protection
against diarrhoea from homologous challenge, but did
not prevent colonization in the New World monkey (Mon-
teiro et al., 2008). Alternatively, secreted proteins can
also be exploited as vaccine candidates. The flagella
apparatus is known to secrete virulence factors (e.g.
FlaC, Cia, FspA1 and FspA2), and vaccination of mice
with recombinant FlaC, FspA1 and FspA2 elicited a
humoral response and yielded partial protection against
homologous challenge (Baqar et al., 2008). Despite
these studies, an effective vaccine against Campylo-
bacter has yet to be developed. As Campylobacter
strains are genetically and antigenically diverse, an ideal
vaccine should have the ability to elicit a protective
immunity against a broad range of Campylobacter
subtypes. Proteomics provides a promising tool for
global profiling of Campylobacter antigens (Scott and
Cordwell, 2009). Combination of proteomics with immu-
noblotting may identify protective antigens for vaccine
development.
The distinct features of Campylobacter biology provide
potential targets for the development of new antimicro-
bials or alternatives to antibiotics. Campylobacter prefer-
entially uses flavodoxins as electron carriers and is pre-
dicted to synthesize menaquinone through the futalosine
pathway (Cremades et al., 2005; Hiratsuka et al., 2008).
The lack of flavodoxins and the futalosine pathway in
humans and their important role in C. jejuni metabolism
make them attractive therapeutic targets. As CmeABC is
a key player in the resistance to antibiotics and in intesti-
nal colonization, inhibition of CmeABC represents a
plausible approach for controlling Campylobacter. A few
studies have explored this possibility using efflux pump
inhibitors, such as phenyl-arginine-b-naphthylamide
(PAbN) and 1-(1-naphthylmethyl)-piperazine (NMP),
which reduced Campylobacter resistance to antibiotics
and bile salts in culture media (Lin and Martinez, 2006;
Gibreel et al., 2007; Hannula and Hanninen, 2008).
However, the tested inhibitors including PAbN had a
limited effect on Campylobacter colonization in chickens
(Lin and Martinez, 2006). To date, CmeABC-specific
inhibitors have not been identified. Elucidation of the
three-dimensional structure of the efflux proteins may
facilitate the design of small molecular blockers that can
be used to inhibit the function of CmeABC. Recently, Jeon
and Zhang (2009) examined the feasibility of using anti-
sense technology to silence the function of CmeABC and
found that a CmeA-specific peptide nucleic acid sensi-
tized C. jejuni to antibiotics. Whether this method can be
optimized for in vivo use in preventing Campylobacter
colonization awaits further investigation. To be effective in
vivo, efflux pump inhibitors must be stable in the gas-
trointestinal tract, have a low toxicity to animal hosts and
specifically target Campylobacter without inhibiting the
normal gut flora.
In summary, the recent advances in understanding
Campylobacter biology have provided us with new oppor-
tunities to develop anti-Campylobacter strategies. As
research efforts expand from the genome to the transcrip-
tome, proteome, glycome, metabolome and metage-
nome, we will be better equipped with biotechnological
tools to control Campylobacter infection in both animal
reservoirs and humans. In addition, the biological systems
in Campylobacter may be exploited for broad biotechno-
logical applications. For example, the N-glycosylation
system in C. jejuni may be used to produce glycosylated
recombinant proteins because this system is functional in
E. coli (Wacker et al., 2002). The PglB enzyme of the C.
jejuni glycosylation pathway was also shown to be able to
transfer the O-polysaccharide from a lipid carrier to an
acceptor protein in E. coli and Salmonella (Feldman et al.,
2005; Wacker et al., 2006). The functionality of the
Campylobacter glycosylation system in heterologous bac-
terial hosts and its relaxed substrate specificity provide a
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suitable system to engineer glycoproteins for various bio-
technological applications, such as production of glyco-
conjugate vaccines.
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